Final KEYNOTE-564 data show Keytruda after kidney cancer surgery lowered the risk of death by 30%. Dr. Toni Choueiri explains ...

The results of a phase 3 trial suggest that a targeted therapy, known as sacituzumab tirumotecan (sac-TMT), was associated with a lower risk of progression and death of endometrial cancer.

Researchers identified molecular switches that push cancer cells into senescence and evade chemotherapy, offering potential ...

The image on the left depicts the features most important to FAHR-FaceSurvival’s predictions of cancer survival outcomes, ...

A new report on cancer in the US shows a steady decline in overall deaths from 2001 through 2022. The rate of diagnoses among men fell from 2001 through 2013 and then stabilized through 2021 but these ...

The growth and death of cancer cells in the lab are studied primarily in two-dimensional cell cultures. In a study published in the journal Developmental Cell on Oct. 14, researchers instead used ...

Separately, Merck reported positive Phase 3 Keynote-C93 results for its blockbuster Keytruda drug as a monotherapy in certain patients with advanced or recurrent endometrial cancer. Keytruda reduced ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Nguyen-Wong Family Steve Wong was 41 years old, athletic, and healthy. “He was the last ...